Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growth

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  To, Catherine ^a,d   Farnsworth, Rae H ^a   Vail, Mary E ^a   Chheang, Chanly ^a   Gargett, Caroline E ^b   Murone, Carmel ^c   Llerena, Carmen ^a   Major, Andrew T ^a   Scott, Andrew M ^c   Janes, Peter W ^a   Lackmann, Martin ^a  

^a MONASH UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN RECEPTOR A3; VASCULOTROPIN RECEPTOR 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; ENDOMETRIUM; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; VASCULARIZATION; ADULT; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL HYPOXIA; CYTOLOGY; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETICS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MULTIPOTENT STEM CELL; NUDE MOUSE; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPLANTATION; WESTERN BLOTTING; XENOGRAFT; YOUNG ADULT;

ADULT; ANIMALS; BLOTTING, WESTERN; CELL HYPOXIA; CELLS, CULTURED; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HETEROGRAFTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MULTIPOTENT STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, EPHA3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS; YOUNG ADULT;

EID: 84913529061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112106     Document Type: Article

References (88)

1. Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9: 677-684.
2. Khakoo AY, Finkel T (2005) Endothelial progenitor cells. Annu Rev Med 56: 79-101.
3. Basile DP, Yoder MC (2014) Circulating and tissue resident endothelial progenitor cells. J Cell Physiol 229: 10-16.
4. Bautch VL (2011) Stem cells and the vasculature. Nat Med 17: 1437-1443.
5. Yoder MC, Ingram DA (2009) Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr Opin Hematol 16: 269-273.
6. Melero-Martin JM, Dudley AC (2011) Concise review: Vascular stem cells and tumor angiogenesis. Stem Cells 29: 163-168.
7. Lin CS, Lue TF (2013) Defining vascular stem cells. Stem Cells Dev 22: 1018-1026.
8. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
9. Bianco P, Robey PG, Simmons PJ (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2: 313-319.
10. Watt SM, Gullo F, van der Garde M, Markeson D, Camicia R, et al. (2013) The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential. Br Med Bull 108: 25-53.
11. Nombela-Arrieta C, Ritz J, Silberstein LE (2011) The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol 12: 126-131.
12. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, et al. (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301-313.
13. Tsai CC, Chen YJ, Yew TL, Chen LL, Wang JY, et al. (2011) Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood 117: 459-469.
14. Tsai CC, Su PF, Huang YF, Yew TL, Hung SC (2012) Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells. Mol Cell 47: 169-182.
15. Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, et al. (2013) The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 19: 35-42.
16. Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/pericyte interactions. Circ Res 97: 512-523.
17. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, et al. (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336.
18. Zhou B, Tsaknakis G, Coldwell KE, Khoo CP, Roubelakis MG, et al. (2012) A novel function for the haemopoietic supportive murine bone marrow MS-5 mesenchymal stromal cell line in promoting human vasculogenesis and angiogenesis. Br J Haematol 157: 299-311.
19. Roura S, Bago JR, Soler-Botija C, Pujal JM, Galvez-Monton C, et al. (2012) Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo. PLoS One 7: e49447.
20. Tang Z, Wang A, Yuan F, Yan Z, Liu B, et al. (2012) Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun 3: 875.
21. Foo SS, Turner CJ, Adams S, Compagni A, Aubyn D, et al. (2006) Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124: 161-173.
22. Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, et al. (2010) Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465: 483-486.
23. Salvucci O, Maric D, Economopoulou M, Sakakibara S, Merlin S, et al. (2009) EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood 114: 1707-1716.
24. Okazaki T, Ni A, Baluk P, Ayeni OA, Kearley J, et al. (2009) Capillary defects and exaggerated inflammatory response in the airways of EphA2-deficient mice. Am J Pathol 174: 2388-2399.
25. Lackmann M, Boyd AW (2008) Eph, a protein family coming of age: more confusion, insight, or complexity? Sci Signal 1: re2.
26. Kuijper S, Turner CJ, Adams RH (2007) Regulation of angiogenesis by Eph-ephrin interactions. Trends Cardiovasc Med 17: 145-151.
27. Salvucci O, Tosato G (2012) Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Adv Cancer Res 114: 21-57.
28. Arthur A, Zannettino A, Panagopoulos R, Koblar SA, Sims NA, et al. (2011) EphB/ephrin-B interactions mediate human MSC attachment, migration and osteochondral differentiation. Bone 48: 533-542.
29. Oates AC, Lackmann M, Power MA, Brennan C, Down LM, et al. (1999) An early developmental role for eph-ephrin interaction during vertebrate gastrulation. Mech Dev 83: 77-94.
30. Iwamasa H, Ohta K, Yamada T, Ushijima K, Terasaki H, et al. (1999) Expression of Eph receptor tyrosine kinases and their ligands in chick embryonic motor neurons and hindlimb muscles. Dev Growth Differ 41: 685-698.
31. Kilpatrick TJ, Brown A, Lai C, Gassmann M, Goulding M, et al. (1996) Expression of the Tyro4/Mek4/Cek4 gene specifically marks a subset of embryonic motor neurons and their muscle targets. Mol Cell Neurosci 7: 62-74.
32. Stephen LJ, Fawkes AL, Verhoeve A, Lemke G, Brown A (2007) A critical role for the EphA3 receptor tyrosine kinase in heart development. Dev Biol 302: 66-79.
33. Boyd AW, Bartlett PF, Lackmann M (2014) Therapeutic targeting of EPH receptors and their ligands. Nat Rev Drug Discov 13: 39-62.
34. Vail M, Murone C, Hii L, Tan A, Abebe D, et al. (2014) Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment. Cancer Research 74: 4470-4481.
35. Gargett CE, Rogers PA (2001) Human endometrial angiogenesis. Reproduction 121: 181-186.
36. Boyd AW, Ward LD, Wicks IP, Simpson RJ, Salvaris E, et al. (1992) Isolation and characterization of a novel receptor-type protein tyrosine kinase (hek) from a human pre-B cell line. J Biol Chem 267: 3262-3267.
37. Lawrenson ID, Wimmer-Kleikamp SH, Lock P, Schoenwaelder SM, Down M, et al. (2002) Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3- expressing 293T and melanoma cells by CrkII and Rho-mediated signalling. J Cell Sci 115: 1059-1072.
38. Vearing C, Lee FT, Wimmer-Kleikamp S, Spirkoska V, To C, et al. (2005) Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents. Cancer Res 65: 6745-6754.
39. Nievergall E, Janes PW, Stegmayer C, Vail ME, Haj FG, et al. (2010) PTP1B regulates Eph receptor function and trafficking. J Cell Biol 191: 1189-1203.
40. Schwab KE, Hutchinson P, Gargett CE (2008) Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells. Hum Reprod 23: 934-943.
41. Chan RW, Schwab KE, Gargett CE (2004) Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod 70: 1738-1750.
42. Smith FM, Vearing C, Lackmann M, Treutlein H, Himanen J, et al. (2004) Dissecting the EphA3/ Ephrin-A5 interactions using a novel functional mutagenesis screen. J Biol Chem 279: 9522-9531.
43. Bieche I, Nogues C, Paradis V, Olivi M, Bedossa P, et al. (2000) Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 6: 452-459.
44. Dottori M, Down M, Huttmann A, Fitzpatrick DR, Boyd AW (1999) Cloning and characterization of EphA3 (Hek) gene promoter: DNA methylation regulates expression in hematopoietic tumor cells. Blood 94: 2477-2486.
45. Adini A, Fainaru O, Udagawa T, Connor KM, Folkman J, et al. (2009) Matrigel cytometry: a novel method for quantifying angiogenesis in vivo. J Immunol Methods 342: 78-81.
46. Gargett CE (2007) Uterine stem cells: what is the evidence? Hum Reprod Update 13: 87-101.
47. Padykula HA (1991) Regeneration in the primate uterus: the role of stem cells. Ann N Y Acad Sci 622: 47-56.
48. Bussolati B, Deambrosis I, Russo S, Deregibus MC, Camussi G (2003) Altered angiogenesis and survival in human tumor-derived endothelial cells. Faseb J 17: 1159-1161.
49. Martin-Rendon E, Hale SJ, Ryan D, Baban D, Forde SP, et al. (2007) Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia. Stem Cells 25: 1003-1012.
50. Bosco MC, Pierobon D, Blengio F, Raggi F, Vanni C, et al. (2011) Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood 117: 2625-2639.
51. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
52. Colter DC, Sekiya I, Prockop DJ (2001) Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 98: 7841-7845.
53. Nievergall E, Lackmann M, Janes PW (2012) Eph-dependent cell-cell adhesion and segregation in development and cancer. Cellular and Molecular Life Sciences 69: 1813-1843.
54. Lackmann M, Mann RJ, Kravets L, Smith FM, Bucci TA, et al. (1997) Ligand for EPH-related kinase (LERK) 7 is the preferred high affinity ligand for the HEK receptor. J BiolChem 272: 16521-16530.
55. Wimmer-Kleikamp SH, Nievergall E, Gegenbauer K, Adikari S, Mansour M, et al. (2008) Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells. Blood 112: 721-732.
56. Adams RH, Alitalo K (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8: 464-478.
57. Okada H, Tsuzuki T, Shindoh H, Nishigaki A, Yasuda K, et al. (2014) Regulation of decidualization and angiogenesis in the human endometrium: mini review. J Obstet Gynaecol Res 40: 1180-1187.
58. Critchley HO, Osei J, Henderson TA, Boswell L, Sales KJ, et al. (2006) Hypoxia-inducible factor-1alpha expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2 (EP2). Endocrinology 147: 744-753.
59. Maybin JA, Battersby S, Hirani N, Nikitenko LL, Critchley HO, et al. (2011) The expression and regulation of adrenomedullin in the human endometrium: a candidate for endometrial repair. Endocrinology 152: 2845-2856.
60. Tsuzuki T, Okada H, Cho H, Tsuji S, Nishigaki A, et al. (2012) Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1alpha and inhibits stromal cell-derived factor-1 in human endometrial stromal cells. Hum Reprod 27: 523-530.
61. Zhang J, Salamonsen LA (2002) Expression of hypoxia-inducible factors in human endometrium and suppression of matrix metalloproteinases under hypoxic conditions do not support a major role for hypoxia in regulating tissue breakdown at menstruation. Hum Reprod 17: 265-274.
62. Vihanto MM, Plock J, Erni D, Frey BM, Frey FJ, et al. (2005) Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin. Faseb J 19: 1689-1691.
63. Gargett CE, Nguyen HP, Ye L (2012) Endometrial regeneration and endometrial stem/progenitor cells. Rev Endocr Metab Disord 13: 235-251.
64. Taylor HS (2004) Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 292: 81-85.
65. Du H, Taylor HS (2007) Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells 25: 2082-2086.
66. Mints M, Jansson M, Sadeghi B, Westgren M, Uzunel M, et al. (2008) Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient. Hum Reprod 23: 139-143.
67. Gargett CE, Chan RW, Schwab KE (2008) Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells. Mol Cell Endocrinol 288: 22-29.
68. Robb AO, Mills NL, Smith IB, Short A, Tura-Ceide O, et al. (2009) Influence of menstrual cycle on circulating endothelial progenitor cells. Hum Reprod 24: 619-625.
69. Verdi J, Tan A, Shoae-Hassani A, Seifalian AM (2014) Endometrial stem cells in regenerative medicine. J Biol Eng 8: 20.
70. Ulrich D, Muralitharan R, Gargett CE (2013) Toward the use of endometrial and menstrual blood mesenchymal stem cells for cell-based therapies. Expert Opin Biol Ther 13: 1387-1400.
71. Bockeria L, Bogin V, Bockeria O, Le T, Alekyan B, et al. (2013) Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic. J Transl Med 11: 56.
72. Ulrich D, Edwards SL, Su K, Tan KS, White JF, et al. (2014) Human endometrial mesenchymal stem cells modulate the tissue response and mechanical behavior of polyamide mesh implants for pelvic organ prolapse repair. Tissue Eng Part A 20: 785-798.
73. Hida N, Nishiyama N, Miyoshi S, Kira S, Segawa K, et al. (2008) Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells 26: 1695-1704.
74. Murphy MP, Wang H, Patel AN, Kambhampati S, Angle N, et al. (2008) Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia? J Transl Med 6: 45.
75. Cui CH, Uyama T, Miyado K, Terai M, Kyo S, et al. (2007) Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Mol Biol Cell 18: 1586-1594.
76. Shoae-Hassani A, Sharif S, Seifalian AM, Mortazavi-Tabatabaei SA, Rezaie S, et al. (2013) Endometrial stem cell differentiation into smooth muscle cell: a novel approach for bladder tissue engineering in women. BJU Int 112: 854-863.
77. Ball SG, Worthington JJ, Canfield AE, Merry CL, Kielty CM (2014) Mesenchymal stromal cells: Inhibiting PDGF receptors or depleting fibronectin induces mesodermal progenitors with endothelial potential. Stem Cells 32: 694-705.
78. Oskowitz A, McFerrin H, Gutschow M, Carter ML, Pochampally R (2011) Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res 6: 215-225.
79. Schwab KE, Gargett CE (2007) Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum Reprod 22: 2903-2911.
80. Masuda H, Anwar SS, Buhring HJ, Rao JR, Gargett CE (2012) A novel marker of human endometrial mesenchymal stem-like cells. Cell Transplant 21: 2201-2214.
81. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, et al. (2010) Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 16: 1400-1406.
82. Sugrue T, Lowndes NF, Ceredig R (2014) Hypoxia enhances the radio-resistance of mouse mesenchymal stromal cells. Stem Cells 32: 2188-2200.
83. Yano H, Uchida H, Iwasaki T, Mukai M, Akedo H, et al. (2000) Paxillin alpha and Crk-associated substrate exert opposing effects on cell migration and contact inhibition of growth through tyrosine phosphorylation. Proc Natl Acad Sci U S A 97: 9076-9081.
84. Yu X, Lu C, Liu H, Rao S, Cai J, et al. (2013) Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury. PLoS One 8: e62703.
85. Rajaraman G, White J, Tan KS, Ulrich D, Rosamilia A, et al. (2013) Optimization and scale-up culture of human endometrial multipotent mesenchymal stromal cells: potential for clinical application. Tissue Eng Part C Methods 19: 80-92.
86. Hagey A, Lancet JE, Palath V, Wei AH, Lackmann M, et al. (2011) A Recombinant Antibody to EphA3 for the Treatment of Hematologic Malignancies: Research Update and Interim Phase 1 Study Results. ASH Annual Meeting Abstracts 118: 4893-.
87. Lancet J, Wei AH, Durrant ST, Hertzberg MS, Swords RT, et al. (2013) A Phase I Study Of KB004, a Novel Non-Fucosylated humaneered ® Antibody, Targeted Against The Receptor Tyrosine Kinase EphA3, In Advanced Hematologic Malignancies. Blood supplement, ASH Annual Meeting Abstracts 122: 3838.
88. Palath V, Vekhande R, Lee A, Williams J, Zhang L, et al. (2009) A Recombinant Human Antibody to EphA3 with Pro-Apoptotic and Enhanced ADCC Activity Shows Selective Cytotoxicity against Myeloid Leukemia Cells and CD123-Positive Leukemic Stem Cells. ASH Annual Meeting Abstracts 114: 1728.